Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marie Foley Kijewski

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
JACC. Cardiovascular Imaging|December 19, 2021
Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful TherapySarah A M Cuddy, Michael Jerosch-Herold, Rodney H Falk, et al.
JACC. Cardiovascular Imaging|July 13, 2024
Prognostic Value of Left Ventricular <sup>18</sup>F-Florbetapir Uptake in Systemic Light-Chain AmyloidosisOlivier F Clerc, Yesh Datar, Sarah A M Cuddy, et al.
JACC. Cardiovascular Imaging|September 12, 2025
Changes in Myocardial Light Chain Amyloid Burden After Plasma Cell TherapyDominik C Benz, Olivier F Clerc, Sarah A M Cuddy, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Myocardial Characterization for Early Diagnosis, Treatment Response Monitoring, and Risk Assessment in Systemic Light-Chain AmyloidosisOlivier F Clerc, Sarah A M Cuddy, Michael Jerosch-Herold, et al.
JACC. Cardiovascular Imaging|July 13, 2024
Myocardial Characteristics, Cardiac Structure, and Cardiac Function in Systemic Light-Chain AmyloidosisOlivier F Clerc, Sarah A M Cuddy, Michael Jerosch-Herold, et al.
Frontiers in Cardiovascular Medicine|June 14, 2024
Mechanisms of left ventricular systolic dysfunction in light chain amyloidosis: a multiparametric cardiac MRI studyEthan Katznelson, Michael Jerosch-Herold, Sarah A M Cuddy, et al.
Circulation. Cardiovascular Imaging|January 30, 2026
Prognostic Significance of Noninvasive Simultaneous Renal and Cardiac Perfusion: Interrogating Mechanisms of Cardiovascular-Kidney InteractionsOmolabake O Alabi, Zhou Lan, Daniel M Huck, et al.
JACC. Cardiovascular Imaging|May 18, 2020
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?Sarah A M Cuddy, Paco E Bravo, Rodney H Falk, et al.
European Heart Journal. Cardiovascular Imaging|January 9, 2024
Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosisYesh Datar, Olivier F Clerc, Sarah A M Cuddy, et al.
Circulation. Cardiovascular Imaging|June 8, 2022
Accuracy and Reproducibility of Myocardial Blood Flow Quantification by Single Photon Emission Computed Tomography Imaging in Patients With Known or Suspected Coronary Artery DiseaseAna Carolina do A H de Souza, Hendrik J Harms, Laurel Martell, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
JACC. Cardiovascular Imaging|December 19, 2021
Myocardial Composition in Light-Chain Cardiac Amyloidosis More Than 1 Year After Successful TherapySarah A M Cuddy, Michael Jerosch-Herold, Rodney H Falk, et al.
JACC. Cardiovascular Imaging|July 13, 2024
Prognostic Value of Left Ventricular <sup>18</sup>F-Florbetapir Uptake in Systemic Light-Chain AmyloidosisOlivier F Clerc, Yesh Datar, Sarah A M Cuddy, et al.
JACC. Cardiovascular Imaging|September 12, 2025
Changes in Myocardial Light Chain Amyloid Burden After Plasma Cell TherapyDominik C Benz, Olivier F Clerc, Sarah A M Cuddy, et al.
Medrxiv : the Preprint Server for Health Sciences|October 24, 2023
Myocardial Characterization for Early Diagnosis, Treatment Response Monitoring, and Risk Assessment in Systemic Light-Chain AmyloidosisOlivier F Clerc, Sarah A M Cuddy, Michael Jerosch-Herold, et al.
JACC. Cardiovascular Imaging|July 13, 2024
Myocardial Characteristics, Cardiac Structure, and Cardiac Function in Systemic Light-Chain AmyloidosisOlivier F Clerc, Sarah A M Cuddy, Michael Jerosch-Herold, et al.
Frontiers in Cardiovascular Medicine|June 14, 2024
Mechanisms of left ventricular systolic dysfunction in light chain amyloidosis: a multiparametric cardiac MRI studyEthan Katznelson, Michael Jerosch-Herold, Sarah A M Cuddy, et al.
Circulation. Cardiovascular Imaging|January 30, 2026
Prognostic Significance of Noninvasive Simultaneous Renal and Cardiac Perfusion: Interrogating Mechanisms of Cardiovascular-Kidney InteractionsOmolabake O Alabi, Zhou Lan, Daniel M Huck, et al.
JACC. Cardiovascular Imaging|May 18, 2020
Improved Quantification of Cardiac Amyloid Burden in Systemic Light Chain Amyloidosis: Redefining Early Disease?Sarah A M Cuddy, Paco E Bravo, Rodney H Falk, et al.
European Heart Journal. Cardiovascular Imaging|January 9, 2024
Quantification of right ventricular amyloid burden with 18F-florbetapir positron emission tomography/computed tomography and its association with right ventricular dysfunction and outcomes in light-chain amyloidosisYesh Datar, Olivier F Clerc, Sarah A M Cuddy, et al.
Circulation. Cardiovascular Imaging|June 8, 2022
Accuracy and Reproducibility of Myocardial Blood Flow Quantification by Single Photon Emission Computed Tomography Imaging in Patients With Known or Suspected Coronary Artery DiseaseAna Carolina do A H de Souza, Hendrik J Harms, Laurel Martell, et al.
Pageof 5